Virtual Medicinal Product (VMP) - Aflibercept 30.1mg/263microlitres solution for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Aflibercept 30.1mg/263microlitres solution for injection vials | Start Date 01-02-2024 | End Date |
| Abbreviated Name | Abbreviated Name Aflibercept 30.1mg/263microlitres inj vials | Start Date 01-02-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 263
- UDFS UOM
- microlitre
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravitreal
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intravitreal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- S01LA05
- BNF Codes
-
- BNF code 11080200
| Code | Start Date | End Date |
|---|---|---|
| 42603511000001107 | 01-02-2024 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Aflibercept | Based on Ingredient Substance | 114.3 mg | 1 ml |
Name
Aflibercept
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
114.3
Strength and UOM (Dmr)
1
Parent Products
-
VTMAflibercept
-
VMP(Current) Aflibercept 30.1mg/263microlitres so...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |